Nu-Med Plus (Nu-Med Plus) 5-Year Dividend Growth Rate : 0.00% (As of Mar. 2024)

View and export this data going back to 2013. Start your Free Trial

What is Nu-Med Plus 5-Year Dividend Growth Rate?

Nu-Med Plus's Dividends per Share for the three months ended in Mar. 2024 was $0.00.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

Nu-Med Plus's Dividend Payout Ratio for the three months ended in Mar. 2024 was 0.00. As of today, Nu-Med Plus's Dividend Yield % is 0.00%.

For more information regarding to dividend, please check our Dividend Page.

Competitive Comparison of Nu-Med Plus's 5-Year Dividend Growth Rate

For the Medical Devices subindustry, Nu-Med Plus's 5-Year Dividend Growth Rate, along with its competitors' market caps and 5-Year Dividend Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Nu-Med Plus's 5-Year Dividend Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Nu-Med Plus's 5-Year Dividend Growth Rate distribution charts can be found below:

* The bar in red indicates where Nu-Med Plus's 5-Year Dividend Growth Rate falls into.

Nu-Med Plus 5-Year Dividend Growth Rate Calculation

This is the average annual rate that a company has been raising its dividends. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

Nu-Med Plus (OTCPK:NUMD) 5-Year Dividend Growth Rate Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

Nu-Med Plus's Dividend Payout Ratio for the quarter that ended in Mar. 2024 is calculated as

Dividend Payout Ratio	=	Dividends per Share (Q: Mar. 2024 )	/	EPS without NRI (Q: Mar. 2024 )
	=	0	/	-0
	=	N/A

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nu-Med Plus 5-Year Dividend Growth Rate Related Terms

Thank you for viewing the detailed overview of Nu-Med Plus's 5-Year Dividend Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Nu-Med Plus (Nu-Med Plus) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Nu-Med Plus Inc (OTCPK:NUMD) » Definitions » 5-Year Dividend Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

640 Belle Terre Road, Building 2 E Port, Jefferson, NY, USA, 11777

Website

https://www.nu-medplus.com

Nu-Med Plus Inc is an medical device company principally engaged in the design, innovation, development, enhancement, and commercialization of beginning, early, and selective later-stage quality medical devices. It focuses on the formulation of Nitric Oxide powder, which is a desktop generator device which delivers inhaled Nitric Oxide to replace expensive pressurized canisters and a mobile rechargeable device to deliver inhaled Nitric Oxide gas to offer solutions to hospitals, health systems and medical community throughout the world.

Executives

William C Hayde	director, officer: CEO	76 CLIFF ROAD, BELLE TERRE NY 11777
Wendy P. Smith	10 percent owner	P. O. BOX 1374, SALT LAKE CITY UT 84110
Brett J. Earl	director, officer: VP of Medical Marketing	P.O. BOX 729, MORGAN UT 84050
Mark Edward Christensen	officer: CFO, Sec, Treas, Prin Acct Off	455 E. 500 S., SUITE 207, SALT LAKE CITY UT 84111
Thomas A Tait	10 percent owner	514 AMERICAS WAY #5556, BOX ELDER SD 57719
Craig Morrison	director, 10 percent owner, officer: Vice President of Technology	975 NORTH TERRACE DRIVE, PROVO UT 84604
William G Moon	director, 10 percent owner, officer: Vice President of Operations	1266 SOUTH 1380 WEST, OREM UT 84058
Jeffrey Lynn Robins	director, 10 percent owner, officer: CEO	455 EAST 500 SOUTH, SUITE #205, SALT LAKE CITY UT 84111